Skip to Content

Clinuvel Pharmaceuticals Ltd

Rating as of

Company Profile

Business Description

Clinuvel Pharmaceuticals Ltd is an Australia-based biopharmaceutical company. It is engaged in developing drugs for the treatment of skin disorders. Its principal compound, SCENESSE is a drug for erythropoietic protoporphyria. Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to harmful UV radiation and at repigmentation of the skin due to a number of depigmentation disorders.

535 Bourke Street, Level 11
Melbourne, VIC, 3000, Australia
T +61 396604900
Sector Healthcare
Industry Biotechnology
Most Recent Earnings
Fiscal Year End Jun 30, 2020
Stock Type
Employees 16